Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dopamine and oxytocin in individual and social performance monitoring
NL-OMON50126Active, not recruiting
- Sponsor
- Leiden University
- Start
- Jan 2020
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of oxytocin, levodopa and Placebo-COD Research Private Ltd (3 arms), sponsored by Leiden University. Primary endpoint: Brain activation across pharmacological conditions. Started Jan 2020; status: active, not recruiting.
02
Drugs
oxytocinlevodopaPlacebo-COD Research Private Ltd
Beyond the preview
Go deeper on NL-OMON50126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50126.